Literature DB >> 27356900

The Influenza A Virus Genotype Determines the Antiviral Function of NF-κB.

Sharmistha Dam1, Michael Kracht2, Stephan Pleschka3, M Lienhard Schmitz4.   

Abstract

UNLABELLED: The role of NF-κB in influenza A virus (IAV) infection does not reveal a coherent picture, as pro- and also antiviral functions of this transcription factor have been described. To address this issue, we used clustered regularly interspaced short palindromic repeat with Cas9 (CRISPR-Cas9)-mediated genome engineering to generate murine MLE-15 cells lacking two essential components of the NF-κB pathway. Cells devoid of either the central NF-κB essential modulator (NEMO) scaffold protein and thus defective in IκB kinase (IKK) activation or cells not expressing the NF-κB DNA-binding and transactivation subunit p65 were tested for propagation of the SC35 virus, which has an avian host range, and its mouse-adapted variant, SC35M. While NF-κB was not relevant for replication of SC35M, the absence of NF-κB activity increased replication of the nonadapted SC35 virus. This antiviral effect of NF-κB was most prominent upon infection of cells with low virus titers as they usually occur during the initiation phase of IAV infection. The defect in NF-κB signaling resulted in diminished IAV-triggered phosphorylation of interferon regulatory factor 3 (IRF3) and expression of the antiviral beta interferon (IFN-β) gene. To identify the viral proteins responsible for NF-κB dependency, reassortant viruses were generated by reverse genetics. SC35 viruses containing the SC35M segment encoding neuraminidase (NA) were completely inert to the inhibitory effect of NF-κB, emphasizing the importance of the viral genotype for susceptibility to the antiviral functions of NF-κB. IMPORTANCE: This study addresses two different issues. First, we investigated the role of the host cell transcription factor NF-κB in IAV replication by genetic manipulation of IAVs by reverse genetics combined with targeted genome engineering of host cells using CRISPR-Cas9. The analysis of these two highly defined genetic systems indicated that the IAV genotype can influence whether NF-κB displays an antiviral function and thus might in part explain incoherent results from the literature. Second, we found that perturbation of NF-κB function greatly improved the growth of a nonadapted IAV, suggesting that NF-κB may contribute to the maintenance of the host species barrier.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27356900      PMCID: PMC4988167          DOI: 10.1128/JVI.00946-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

Review 1.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

Review 2.  Type I interferons in host defense.

Authors:  Daniel B Stetson; Ruslan Medzhitov
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

3.  Nuclear trafficking of influenza virus ribonuleoproteins in heterokaryons.

Authors:  G Whittaker; M Bui; A Helenius
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

4.  The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation.

Authors:  Katarzyna Bulek; Caini Liu; Shadi Swaidani; Liwen Wang; Richard C Page; Muhammet F Gulen; Tomasz Herjan; Amina Abbadi; Wen Qian; Dongxu Sun; Mark Lauer; Vincent Hascall; Saurav Misra; Mark R Chance; Mark Aronica; Thomas Hamilton; Xiaoxia Li
Journal:  Nat Immunol       Date:  2011-08-07       Impact factor: 25.606

5.  Spread of infection and lymphocyte depletion in mice depends on polymerase of influenza virus.

Authors:  Gülsah Gabriel; Karin Klingel; Oliver Planz; Katja Bier; Astrid Herwig; Martina Sauter; Hans-Dieter Klenk
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

6.  Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza viruses.

Authors:  Yukiko Muramoto; Jason E Shoemaker; Mai Quynh Le; Yasushi Itoh; Daisuke Tamura; Yuko Sakai-Tagawa; Hirotaka Imai; Ryuta Uraki; Ryo Takano; Eiryo Kawakami; Mutsumi Ito; Kiyoko Okamoto; Hirohito Ishigaki; Hitomi Mimuro; Chihiro Sasakawa; Yukiko Matsuoka; Takeshi Noda; Satoshi Fukuyama; Kazumasa Ogasawara; Hiroaki Kitano; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

7.  Clinical aspects and cytokine response in severe H1N1 influenza A virus infection.

Authors:  Natalia Hagau; Adriana Slavcovici; Daniel N Gonganau; Simona Oltean; Dan S Dirzu; Erika S Brezoszki; Mihaela Maxim; Constantin Ciuce; Monica Mlesnite; Rodica L Gavrus; Carmen Laslo; Radu Hagau; Magda Petrescu; Daniela M Studnicska
Journal:  Crit Care       Date:  2010-11-09       Impact factor: 9.097

8.  NF-κB and IRF pathways: cross-regulation on target genes promoter level.

Authors:  Marta Iwanaszko; Marek Kimmel
Journal:  BMC Genomics       Date:  2015-04-17       Impact factor: 3.969

9.  The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm.

Authors:  Han Xiao; Marian J Killip; Peter Staeheli; Richard E Randall; David Jackson
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

Review 10.  Molecular control of the NEMO family of ubiquitin-binding proteins.

Authors:  Kristopher Clark; Sambit Nanda; Philip Cohen
Journal:  Nat Rev Mol Cell Biol       Date:  2013-08-29       Impact factor: 94.444

View more
  4 in total

1.  Phosphoproteome Analysis of Cells Infected with Adapted and Nonadapted Influenza A Virus Reveals Novel Pro- and Antiviral Signaling Networks.

Authors:  Axel Weber; Sharmistha Dam; Vera V Saul; Irina Kuznetsova; Christin Müller; Karin Fritz-Wolf; Katja Becker; Uwe Linne; Hongbo Gu; Matthew P Stokes; Stephan Pleschka; Michael Kracht; M Lienhard Schmitz
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

2.  Classical Drug Digitoxin Inhibits Influenza Cytokine Storm, With Implications for Covid-19 Therapy.

Authors:  Bette S Pollard; Jorge C BLANCOl; John R Pollard
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

3.  Dual Host and Pathogen RNA-Seq Analysis Unravels Chicken Genes Potentially Involved in Resistance to Highly Pathogenic Avian Influenza Virus Infection.

Authors:  Albert Perlas; Jordi Argilaguet; Kateri Bertran; Raúl Sánchez-González; Miquel Nofrarías; Rosa Valle; Antonio Ramis; Martí Cortey; Natàlia Majó
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

Review 4.  Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections.

Authors:  Brianna J Stubbs; Andrew P Koutnik; Emily L Goldberg; Vaibhav Upadhyay; Peter J Turnbaugh; Eric Verdin; John C Newman
Journal:  Med (N Y)       Date:  2020-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.